Differential expression of p53 and Ki-67 proteins in classic and iatrogenic Kaposi's sarcoma

American Journal of Dermatopathology

Volumn 21, Issue 2, 1999, Pages 138-145

  Hodak, Emmilia ^a   Hammel, Ilan ^b   Feinmesser, Meora ^a   Zelinger, Almog ^a   Maron, Lea ^a   Sulkes, Jaqueline ^a   David, Michael ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Classic Kaposi's sarcoma; Iatrogenic Kaposi's sarcoma; Ki 67 protein expression; P53 protein expression

Indexed keywords

AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPOSI SARCOMA; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IATROGENIC DISEASE; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; SARCOMA, KAPOSI; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032937799     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199904000-00005     Document Type: Article

References (54)

1. Bachbinder A, Friedman-Kien AE. Clinical aspects of Kaposi's sarcoma. Curr Opin Oncol 1992;4:867-74.
2. Brunson ME, Balakrishnan K, Penn I. HLA and Kaposi's sarcoma in solid organ transplantation. Human Immunol 1990;29:56-63.
3. Trattner A, Hodak E, David M, Sandbank M. The appearance of Kaposi's sarcoma during corticosteroid therapy. Cancer 1993;72: 1779-83.
4. Farge D. Kaposi's sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France. Ear J Med 1993;2:339-43.
5. Lever WF, Schaumburg-Lever G. Tumors of vascular tissues. Histopathology of the skin. 7th ed. Philadelphia: JB Lippincott, 1990:704-7.
6. Friedman-Birnbaum R, Bergman R, Bitterman-Deutsch O, Weltfriend S, Lichtig C. Classic and iatrogenic Kaposi's sarcoma. Histopathological patterns as related to course. Am J Dermatopathol 1993;15:523-7.
7. Armes J. A review of Kaposi's sarcoma. Adv Cancer Res 1989; 53:73-87.
8. Domagala W, Harezga B, Szadowska A, Markiewski M, Weber K, Osborn M. Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas. Am J Pathol 1993;142:669-74.
9. Gorczyca W, Markiewski M, Kram A, Tuziak T, Domagala W. Immunohistochemical analysis of bcl-2 and p53 expression in breast carcinomas: their correlation with Ki-67 growth fraction. Virchows Arch 1995;426:229-33.
10. Bergman R, Ramon M, Kilim S, Lichtig C, Friedman-Birnbaum R. An immunohistochemical study of p53 protein expression in classical Kaposi's Sarcoma. Am J Dermatopathol 1996;18:367-70.
11. Dei Tos AP, Doglioni C, Laurino L, Barbareschi M, Fletcher CDM. p53 protein expression in non-neoplastic lesions and benign and malignant neoplasms of soft tissue. Histopathology 1993;22: 45-50.
12. Dada MA, Chetty R, Biddolph SC, Schneider JW, Gatter KR. The immunoexpression of bcl-2 and p53 in Kaposi's sarcoma. Histopathology 1996;29:159-63.
13. Li JJ, Huang YAQ, Cockerell CJ, Zhang WG, Nicolaides A, Friedman-Kien ARE. Expression and mutation of the tumor suppressor gene p53 in AIDS-associated Kaposi's sarcoma. Am J Dermatopathol 1997;19:373-8.
14. Noel JC, De Their F, Simonart T, Andre J, Hermans P, Van Vooren JP, Heenen M. p53 overexpression is a common but late event in the pathogenesis of iatrogenic and AIDS-related Kaposi's sarcoma. Arch Dermatol Res 1997;289:660-1.
15. Harawi SJ, Kaposi's sarcoma. In: Harawi SJ, O'Hara CJ, eds. Pathology and pathophysiology of AIDS and HIV-related diseases. St. Louis: CV Mosby, 1989;83-131.
16. Gerdes J, Li L, Schlueter C, et al. Immunohistochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991;138:867-73.
17. Cattoretti G, Becker MH, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 5) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
18. DeLellis RA. Does the evaluation of proliferative activity predict malignancy or prognosis in endocrine tumors. Hum Pathol 1995; 26:131-4.
19. Marx J. How p53 suppresses cell growth. Science 1993;262: 1641-5.
20. Harris CC. p53: At the crossroads of molecular carcinogenesis and risk assessment. Science 1993;262:1980-1.
21. Hall PA, Lane DP. p53 in tumor pathology: can we trust immunohistochemistry? - revisited. J Pathol 1994;172:1-4.
22. Hall PA, McKee PH, DuMenage H, Dover R, Lane DP. High levels of p53 protein in UV-irradiated normal human skin. Oncogene 1993;8:203-7.
23. Soini Y, Kamel D, Paakko P, Lehto VP, Oikarinem A, Vahakangas K. Aberrant accumulation of p53 associates with Ki-67 and mitotic count in benign skin lesions. Br J Dermatol 1994;131:514-20.
24. Wynford-Thomas D. p53 in tumor pathology: can we trust immunohistochemistry? J Pathol 1992;166:329-30.
25. Stark LA, Arends MJ, McLaren KM, Shahidullah H, Hunter JA, Bird CC. Accumulation of p53 is associated with tumor progression in cutaneous lesions of renal allograft recipients. Br J Cancer 1994;70:662-7.
26. Lu Y, Park SH, Thompson TC, Lane DP. ras-induced hyperplasia occurs with mutation of p53 tumor suppressor protein but activated ras and myc together can induce a carcinoma without p53 mutation. Cell 1992;70:153.
27. Vousden K. Interactions of HPV transforming proteins with products of tumor suppressor genes. FASEB J 1993;7:872.
28. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990; 248:76-9.
29. Scheffner M, Werness BA, Huibreglse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papilloma virus type 16 and 18 promotes degradation of p53. Cell 1990;63:1129-36.
30. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpes-virus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
31. Siegal B, Levinton-Kriss S, Schiffer A, et al. Kaposi's sarcoma in immuno-suppression: possibly the result of a dual viral infection. Cancer 1990;65:492-8.
32. Huang YQ, Li JJ, Rush MG, et al. HPV-16-related DNA sequences in Kaposi's sarcoma. Lancet 1992;339:515-8.
33. Nickoloff BJ, Huang YO, Li JJ, Friedman-Kien ARE. Immunohistochemical detection of papillomavirus antigens in Kaposi's sarcoma. Lancet 1992;339:548-9.
34. Scinicariello F, Dolan MJ, Nedelcu I, Tyring SK, Hilliaro JK. Occurrence of human papillomavirus and p53 gene mutations in Kaposi's sarcoma. Virology 1994;203:153-7.
35. Gruber SA, Matas AJ. Etiology and pathogenesis of tumors occurring after organ transplantation. Transplant Sci 1994;4:87-104.
36. Biggar RJ, Dunsmore N, Kurman RJ, et al. Failure to detect human papillomavirus in Kaposi's sarcoma. Lancet 1992;339:1604-5.
37. Noel JC, Andre J, Hermans P, et al. Kaposi's sarcoma: evaluation of the role of human papillomaviruses. A study using the high sensitivity hot-start polymerase chain reaction detector method and a review of the literature. Arch Dermatol Res 1996;283:786-8.
38. Szekely L, Selivanuova G, Magnusson KP, Klein G, Wiman KG. EBNA-5 an Epstein-Barr virus encoded nuclear antigen binding to the retinoblastoma and p53 proteins. Proc Natl Acad Sci USA 1993;90:5455-9.
39. Drut R, Drut RM. EBV-associated Kaposi's sarcoma in pediatric renal transplant recipient. Pediatr Pathol 1994;14:863-72.
40. Henghold WB, Purvis SF, Schaffer J, Leonard DGB, Gian CZ, Wood GS. Kaposi's sarcoma-associated herpes virus-human herpes virus type 8 and Epstein-Barr virus in iatrogenic Kaposi's sarcoma. Arch Dermatol 1997;133:109-11.
41. Khorshid SM, Glover MT, Churchill L, McGregor JM, Proby CM. p53 immunoreactivity in non-melanoma skin cancer from immunosuppressed and immunocompetent individuals: a comparative study of 246 tumours. J Cut Pathol 1996;23:229-33.
42. MacPhail LA, Dekker NP, Regezi JA. Macrophages and vascular adhesion molecules in oral Kaposi's sarcoma. J Cutan Pathol 1996;23:464-72.
43. Haupt HM, Stern JB, Multhaupt H, Newman HW. Argyrophilic nucleolar organizer regions and proliferating cell nuclear antigen/ cyclin in Kaposi's sarcoma: comparison with morphology and with immunoperoxidase staining for factor VIII-related antigen. Arch Pathol Lab Med 1995;119:538-41.
44. Costa MJ, Walls J, Ames P, Roth LM. Transformation in recurrent ovarian granulosa cell tumors: Ki-67 (MIB-1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior. Hum Pathol 1996;27:274-81.
45. Deb S, Jackson CT, Subler MA, Martin DW. Modulation of cellular and viral promoters by mutant human p53 protein found in tumor cells. J Virol 1992;66:6164-70.
46. Mercer WE, Shields MT, Lin D, Apella E, Ullrich SJ. Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression. Proc Natl Acad Sci USA 1991;88:1958-62.
47. Ostrowski JL, Sawan A, Henry L, et al. p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study. J Pathol 1991;164:75-81.
48. Quinlan DC, Davidson AG, Summers CL, Warden HE, Doshi HM. Accumulation of p53 protein correlates with poor prognosis in human lung cancer. Cancer Res 1992;52:4828-31.
49. Sahin AA, Ro J, Ro JY, et al. Ki-67 immunostaining in node-negative stage I/II breast carcinoma: significant correlation with prognosis. Cancer 1991;68:549-57.
50. Xerri L, Bouabdallah R, Camerlo J, Hassoun J. Expression of the p53 gene in Hodgkin's disease: dissociation between immunohistochemistry and clinicopathological data. Hum Pathol 1994;25: 443-54.
51. Katoh K, Bray CE, Suzuki K, et al. Growth activity in hyperplastic and neoplastic human thyroid determined by an immunohistochemical staining procedure using monoclonal MIB-I. Hum Pathol 1995;26:139-46.
52. Emanuels AG, Burger MP, Hollema H, Koudstaal J. Quantitation of proliferation-associated markers Ag-NOR and Ki-67 does not contribute to the production of lymph node metastases in squamous cell carcinoma of the vulva. Hum Pathol 1996;27:807-11.
53. Kaaya EE, Parravicini C, Sundelin B, et al. Spindle cell ploidy and proliferation in endemic and epidemic Kaposi's sarcoma. Eur J Cancer 1992;28A:11:1890-4.
54. Neidt GW, Myskowski PL, Urmacher C, Neidzwiecki D, Chapman D, Krown SE, Safai B. Histologic predictors of survival in acquired immunodeficiency syndrome-associated Kaposi's sarcoma. Hum Pathol 1992;23:1419-26.